OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - MEDTRONIC Stock

Certificat

DE000SN2N300

Delayed Deutsche Boerse AG 02:51:40 2024-06-07 EDT
2.5 EUR -0.40% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - MEDTRONIC
Current month-5.99%
1 month-3.83%
Date Price Change
24-06-07 2.5 -0.40%
24-06-06 2.51 -0.79%
24-06-05 2.53 +3.27%
24-06-04 2.45 -3.16%
24-06-03 2.53 -5.24%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 02:51 am

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SN2N30
ISINDE000SN2N300
Date issued 2022-05-30
Strike 109.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.92
Lowest since issue 1.36
Spread 0.04
Spread %1.57%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
82.34 USD
Average target price
94.07 USD
Spread / Average Target
+14.24%
Consensus